Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy
Authors
Keywords
Postmyocarditic virus-induced cardiomyopathy, Bone marrow-derived progenitor cells, Vascular cell adhesion molecule-1, Granulocyte colony-stimulating factor
Journal
BASIC RESEARCH IN CARDIOLOGY
Volume 108, Issue 6, Pages -
Publisher
Springer Nature
Online
2013-09-25
DOI
10.1007/s00395-013-0388-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic modifications in cardiovascular disease
- (2012) Johan M. Lorenzen et al. BASIC RESEARCH IN CARDIOLOGY
- Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy
- (2012) Gian Paolo Fadini et al. BASIC RESEARCH IN CARDIOLOGY
- Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart
- (2012) Stephanie Buccini et al. BASIC RESEARCH IN CARDIOLOGY
- Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond
- (2011) Santosh K. Sanganalmath et al. BASIC RESEARCH IN CARDIOLOGY
- Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation
- (2011) Junxi Wu et al. BASIC RESEARCH IN CARDIOLOGY
- Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
- (2011) Hans D. Theiss et al. Stem Cell Research
- Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy
- (2010) Ali Yilmaz et al. CIRCULATION
- Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy
- (2010) Marc-Michael Zaruba et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) — Rationale, design and first interim analysis
- (2010) Hans D. Theiss et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide
- (2010) Kana Shimada et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
- (2010) Volker Rudolph et al. NATURE MEDICINE
- Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
- (2009) Marc-Michael Zaruba et al. Cell Stem Cell
- Sudden Deaths in Young Competitive Athletes
- (2009) Barry J. Maron et al. CIRCULATION
- Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis — ongoing inflammation and an imbalance of the matrix degrading system
- (2009) Susanne Rutschow et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Myocarditis
- (2009) Leslie T. Cooper NEW ENGLAND JOURNAL OF MEDICINE
- G-CSF treatment after myocardial infarction: Impact on bone marrow—derived vs cardiac progenitor cells
- (2008) Stefan Brunner et al. EXPERIMENTAL HEMATOLOGY
- Stem cell mobilisation for myocardial repair
- (2008) Stefan Brunner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction
- (2008) Dietlind Zohlnhöfer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started